Leukemia
Leukemia apoptosis induced by dehydroxymethylepoxyquinomicin
Published in Blood Weekly, July 13th, 2006
According to recent research from Japan, "CLL is a low-grade lymphoid malignancy incurable with conventional modalities of chemotherapy. Strong and constitutive nuclear factor kappa B (NF-kappa B) activation is a characteristic of CLL cells."
"We examined the effects of a new NF-kappa B inhibitor, DHMEQ, on CLL cells. Dehydroxymethylepoxyquinomicin completely abrogated constitutive NF-kappa B activity and induced apoptosis of CLL cells. Apoptosis induced by DHMEQ was accompanied by downregulation of NF-kappa B-dependent...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-07-13)
More Articles from Blood Weekly
- Blood Banking
Autologous whole blood may not need to be discarded after prolonged filtration - Blood Banking
Immunomagnetic separation technologies compared for T cell depletion from buffy coats - Genetics & Genomics
Increased cardiovascular risk is associated with tissue plasminogen activator haplotypes - Acute Myeloid Leukemia
Acute myeloid leukemia managed on outpatient basis - Allergy & Immunology
Platelets target dendritic cell differentiation and production of proinflammatory cytokines - Angiology
CABG patency may be assessed with a magnetic resonance spin echo sequence - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
